When changing from an IL-17 to an IL-23 or vice versa, how long do you typically wait before initiating a new drug?
Featuring Benjamin Lockshin, MD |
EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD
Related CME
Related Media
Powered by Polaris TM